Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Altimmune (ALT) Intangibles: 2015-2022

Historic Intangibles for Altimmune (ALT) over the last 8 years, with Dec 2022 value amounting to $12.4 million.

  • Altimmune's Intangibles changed negligibly% to $12.4 million in Q3 2023 from the same period last year, while for Sep 2023 it was $12.4 million, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $12.4 million for FY2022, which is 9.90% down from last year.
  • According to the latest figures from FY2022, Altimmune's Intangibles is $12.4 million, which was down 9.90% from $13.8 million recorded in FY2021.
  • Altimmune's 5-year Intangibles high stood at $38.9 million for FY2018, and its period low was $12.4 million during FY2022.
  • For the 3-year period, Altimmune's Intangibles averaged around $13.3 million, with its median value being $13.6 million (2020).
  • Per our database at Business Quant, Altimmune's Intangibles rose by 1.64% in 2018 and then crashed by 62.83% in 2019.
  • Yearly analysis of 5 years shows Altimmune's Intangibles stood at $38.9 million in 2018, then tumbled by 62.83% to $14.5 million in 2019, then declined by 5.96% to $13.6 million in 2020, then rose by 1.43% to $13.8 million in 2021, then decreased by 9.90% to $12.4 million in 2022.